22:14 , Jun 14, 2019 |  BioCentury  |  Emerging Company Profile

Sherlock: Leveraging CRISPR, synthetic biology for diagnostics

By taking advantage of two hot technologies, Sherlock is developing a pair of molecular diagnostics that can be used alone or together to rapidly and accurately detect disease in a wide variety of applications. Sherlock...
05:18 , Apr 26, 2019 |  BC Week In Review  |  Financial News

Sherlock adds $14M to series A

CRISPR diagnostic company Sherlock raised an additional $14 million in its series A round Tuesday, closing the round at $31.5 million and bringing the biotech's total funding to $49 million. Northpond Ventures, Baidu Ventures and...
18:28 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Sequoia China leads seed round for next-gen T cell therapy play

RootPath Inc. (Cambridge, Mass.) raised on Aug. 30 $7 million in a seed round led by Sequoia China. Fellow new investors Volcanics Venture, Baidu Ventures and Nest.Bio Ventures also participated. Co-founder and CEO Xi Chen...
11:00 , Aug 30, 2018 |  BC Extra  |  Financial News

Sequoia China leads seed round for next-gen T cell therapy play

RootPath Inc. (Cambridge, Mass.) raised $7 million in a seed round led by Sequoia China. Fellow new investors Volcanics Venture, Baidu Ventures and Nest.Bio Ventures also participated. Co-founder and CEO Xi Chen told BioCentury the...
17:48 , Jul 20, 2018 |  BC Week In Review  |  Financial News

Quantapore raises $15.6M

Genomic sequencing company Quantapore Inc. (Menlo Park, Calif.) raised $15.6 million on July 18 through the sale of series 3 preferred stock. Northern Light Venture Capital led the offering with participation from Tsingyuan Ventures, Sangel...
19:17 , Apr 19, 2018 |  BC Innovations  |  Emerging Company Profile

Engine power

Engine Biosciences Pte. Ltd. is marrying a CRISPR-Cas9 genetic perturbation screen with machine learning to delineate how combinations of genes contribute to disease phenotypes and thereby identify novel targets for a range of diseases. The...
18:24 , Mar 9, 2018 |  BC Week In Review  |  Financial News

AI drug discovery company Atomwise raises $51M series A

Artificial intelligence-based drug discovery company Atomwise Inc. (San Francisco, Calif.) raised $45 million in a series A round on March 7 led by new investors Monsanto Growth Ventures and B Capital Group and seed investor...
12:02 , Mar 7, 2018 |  BC Extra  |  Financial News

AI drug discovery company Atomwise raises $51M series A

Artificial intelligence-based drug discovery company Atomwise Inc. (San Francisco, Calif.) raised $45 million in a series A round Wednesday led by new investors Monsanto Growth Ventures and B Capital Group and seed investor DCVC. Also...
20:19 , Feb 2, 2018 |  BC Week In Review  |  Financial News

Engine raises $10M seed round

AI and genomics company Engine Biosciences Pte. Ltd. (San Francisco, Calif.) raised $10 million on Jan. 31 in an oversubscribed seed financing led by DHVC and 6 Dimensions Capital. Also participating were WuXi AppTec Co....
20:03 , Jan 31, 2018 |  BC Extra  |  Financial News

Engine raises $10M seed round

AI and genomics company Engine Biosciences Pte. Ltd. (San Francisco, Calif.) raised $10 million in an oversubscribed seed financing led by DHVC and 6 Dimensions Capital. Also participating were WuXi AppTec Co. Ltd. (Shanghai, China),...